All News

Emergency contraception policy sparks debate.

California pharmacy board is stepping up its enforcement of its pharmacy consultation with stiffer fines.

In the face of increasing pharmacy costs at Delaware, Maryland, and Virginia pharmacies, health plans push beneficiaries to mail-order facilities

Rite Aid integration of Brooks Eckerd stores progressing

Baxa replaces malfunctioning IV mixing software

FDA approves 300-mg strength of clopidogrel

CMS announces details of the 2008 prescription drug plans

FDA orders unapproved hydrocodone makers to cease marketing

Teamsters at AmerisourceBergen to rally for fair contract settlement.

NACDS applauds passage of House bill to delay tamper-resistant paper requirement

QIO sets up new MTM program for Maryland and District of Columbia

PhRMA testifies to Congress about the threat of drug counterfeiting

Wal-Mart expands its $4 generic plan to include more generics and adds birth control Rxs for $9.

Massachusetts hospitals paying for errors

FDA warns of adverse effects with buccal fentanyl use.

The Senate passed legislation delaying implementation of the Medicaid rule mandating tamper-resistant Rx pads and awaits House action.

Generic versions of Marinol should be classified as Schedule III when they are approved, according to the Drug Enforcement Administration

Medicare keeping limits on anemia drugs

Genetic differences predict anti-inflammatory benefits from nutritional products

Shop 'n Save Pharmacy to provide Vitality Check wellness service

NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists

College of Pharmacy gets new home

NACDS debunks New York Times article, "The 'Poisonous Cocktail' of Multiple Drugs"

Inflated average wholesale prices issued by two publishers have resulted in high costs for consumers, who have filed class-action suits against them.

Oripavine is designated a Schedule II controlled substance by the Drug Enforcement Administration

National Quality Forum releases standards for substance abuse treatment

New on-line tool for calculating pain medication index

TWC Global issues recall of Axcil and Desirin